The Damon Runyon Cancer Research Foundation panel

March 8, 2013  By Steven E. Greer, MD

We interviewed three of the oncologists and industry executives who spoke at the Damon Runyon Continue reading

Posted in - Biotech, - Pharma, Harvard, Oncology | Leave a comment

The IOM report on counterfeit and substandard drugs

Prashant Yadav, PhD, Director, Health Care Research Initiative, University of Michigan, discusses Continue reading

Posted in - Policy, Univ Michigan | Leave a comment

Double arm transplantation

Gerald Brandacher, MD, Scientific Director of the  Composite Tissue Allotransplantation (Reconstructive Transplant) Program at Johns Hopkins discusses the first double arm transplant.

Posted in Johns Hopkins, Plastic surgery | Leave a comment

Wall Street Journal articles

Greer SE. Inside ObamaCare’s Grant-Making. Op-Ed in The Wall Street Journal. June 4, 2012

Greer SE. Pork is Clogging CMMI’s Arteries. Letter section in The Wall Street Journal. June 20, 2012

Avastin for breast cancer

Posted in - Opinion | Comments Off on Wall Street Journal articles

New therapies for Multiple Sclerosis

Interviewed by Steven E. Greer, MD

Barbara Giesser, MD, neurologist and Medical Director of the Multiple Sclerosis Center at UCLA, discusses the Continue reading

Posted in Neurology, UCLA, Uncategorized | Leave a comment

High fructose consumption and fatty liver disease

Manal F. Abdelmalek, MD, MPH, of the Duke Medical Center’s Division of Gastroenterology/Hepatology Continue reading

Posted in Diabetes and endocrinology, Duke, FDA, Pediatrics | Leave a comment

Will medical centers be able to change leadership structure to conform to the PPACA “ObamaCare”?

June 30, 2012, by Steven Greer, MD

The Supreme Court ruled that the PPACA “ObamaCare” law was constitutional in most aspects. Continue reading

Posted in - Policy, Cardiology, Congress, Univ Maryland | Leave a comment

RomneyCare ballooned healthcare costs in Massachusetts

June 24, 2012

CBS News interviewed the Governor of Massachusetts, Deval Patrick, about the cost increases Continue reading

Posted in CMS, Congress | Leave a comment

Pork Is Clogging CMMI’s Arteries

Center for Medicare and Medicaid Innovation Director Richard Gilfillan’s reply (Letters, June 14) to my op-ed of June 5 says that my accusations “are baseless.” This was backed up with no supporting evidence to refute my claims. He simply states that the contract company which operated the grant review reported no malfunctions. But that was the maddening part of my CMMI experience: CMMI did not seem to want to acknowledge any flaws in its system. Perhaps the reason for this was to allow the CMS officials to claim, “There is no record of any other complaints that the system to review applications wasn’t working.”

I sent an email to Dr. Gilfillan and his boss, Health and Human Services Secretary Kathleen Sebelius, so Dr. Gilfillan’s claim that he received no reports of complaints about the system is false. My peer-review team also sent complaints.

After my op-ed, and despite a new House oversight investigation having been initiated, CMMI is still rushing out more political favors in the form of “grants” to beat the Supreme Court ruling on the ObamaCare law. On June 15 CMMI announced 81 more “Innovation awards,” with each grant in the order of $20 million.

Continue reading

Posted in - Opinion, CMS | Leave a comment

Inside ObamaCare’s Grant-Making: CMMI

June 4, 2012- In the Wall Street Journal Op-Ed section– by Steven E. Greer

Early this year, I was briefly involved with one of the Affordable Care Act’s bureaucracies called Continue reading

Posted in - Opinion, - Policy, CMS | Leave a comment

Does Steve Nissen manipulate the media?

April 5, 2010 Opinion By Steven E. Greer, MD

The New York Times recently ran a front-page story raising concern about expanding the indication for statins to people with normal cholesterol levels, per the Crestor JUPITER trial. The article mentioned the new data in Lancet that suggest a diabetes risk from taking statins and compared that risk to the low absolute benefit from the statins. As has become common practice in the mainstream media, Dr. Steve Nissen was interviewed and quoted in the article. Dr. Nissen has been paid by AstraZeneca, maker of Crestor, and many other drug companies, but states that the funds were donated to charity and that there were no tax deduction benefits to him.  Continue reading

Posted in - Opinion, - Policy, Cardiology, Cleveland Clinic | Leave a comment

Reasons to Abandon Low-Density Lipoprotein Cholesterol Targets

Interviewed by Steven Greer, MD

Harlan Krumholz, MD, cardiologist from Yale, discusses his open letter in the journal Circulation Continue reading

Posted in - Policy, Cardiology, CMS, FDA, NIH, Yale | Leave a comment

Update on the DEA’s efforts to curb the “pain pill mill” problem in Florida

March 7, 2012  By Steven Greer, MD

We previously interviewed Special Agent Mark Trouville, the DEA agent in charge of tackling the rampant abuse of prescription opioid pain pills in Florida, and the “pain pill mill” system. Continue reading

Posted in - Policy, Congress, Rehab | Leave a comment

Steven Greer, MD discusses healthcare jobs, ways to reduce hospital error, and the problems with fee for service

February 22, 2012

Posted in - Policy, Univ Kentucky | Leave a comment

Book review: My Beef with Meat

Publisher: Grand Central Life & Style, Hachette Book Group

Review by Steven E. Greer, MD

What do all of these extremely athletic and strong professional athletes have in common? Heavyweight Continue reading

Posted in - Reviews, books, devices | Leave a comment

The inadequate FDA medical device safety surveillance system: a case study

January 25, 2012 By Steven Greer, MD

I have worn contact lenses for more than twenty years without any problems. But recently, Continue reading

Posted in - Medical Devices, - Opinion, Congress, FDA | Leave a comment

The only 5-minutes of the Edwards Sapien AdCom you need to watch

Update: June 11, 2012

The FDA briefing documents for the June 13 advisory committee to review the PARTNER- Continue reading

Posted in - Medical Devices, Cardiac surgery, Cardiology, FDA | Leave a comment

Matthews Chacko, MD: Renal denervation to treat HTN

December 29, 2010

Many medical devices cause a far greater clinical impact than pharmaceutical therapies such Continue reading

Posted in - Medical Devices, Cardiology, Johns Hopkins | Leave a comment

The CardioMEMS’ heart failure pressure measurement system

By Steven Greer, MD

The CardioMEMS’ heart failure pressure measurement system will be evaluated by an FDA Continue reading

Posted in - Medical Devices, Cardiology, FDA, Ohio State | Leave a comment

Cardiology genomic, stem cell, and interventional research at U. Miami

May 13, 2011- The Healthcare Channel hosted, in conjunction with Mark Schoenebaum of ISI, a tour of the Continue reading

Posted in Cardiology, Genetics, Univ Miami | Leave a comment